Todd M. DuChene, who holds the position of Chief Legal and Administrative Officer at Core Scientific, Inc., reported the sale of 10,000 shares of the company's common stock on June 8, 2026. The total value derived from this transaction stands at $268,480. This disposal of equity was not executed as a single block but was split into two distinct transactions, each with specific pricing metrics.
In the initial transaction, DuChene disposed of 5,500 shares. The weighted average price for this portion was recorded at $26.6376 per share. The execution of this block involved multiple individual trades, with the sale prices fluctuating between $25.96 and $26.95. The subsequent transaction involved the sale of the remaining 4,500 shares. This second block carried a weighted average price of $27.1053 per share. Individual sale prices within this transaction ranged from $26.97 to $27.29. When aggregated, the overall weighted average prices for the total 10,000 shares sold ranged from $26.6376 to $27.1053.
All transactions were executed in compliance with a Rule 10b5-1 trading plan. This automated trading arrangement was originally adopted by DuChene on December 5, 2025. The use of this plan indicates that the sales were pre-scheduled rather than reactive to immediate market conditions. Following the completion of these sales, DuChene's direct ownership of Core Scientific common stock stands at 2,068,895 shares.
The insider sale occurs against a backdrop of significant price movement for Core Scientific. Over the past year, the stock has experienced a surge of 112%. Despite this substantial appreciation, the equity remains characterized by high volatility, evidenced by a beta coefficient of 5.48. Analysis from InvestingPro suggests that the stock may be trading at overvalued levels relative to current fundamentals.
Core Scientific's operational context is shifting. The company recently reported its first-quarter 2026 earnings, which displayed mixed financial results. The firm recorded a loss with an earnings per share of -1.06 USD. Revenue for the period reached 115.24 million USD. This financial profile reflects the company's ongoing structural transition from Bitcoin mining operations to colocation infrastructure. Supporting this shift, BTIG recently raised its price target on Core Scientific to $33 from $23, while maintaining a Buy rating. This adjustment followed the company's expansion of approximately 1.2 gigawatts of approved power capacity. A key component of this expansion is a new 430-megawatt site located in Hunt County, Texas.
Corporate governance updates also accompany these operational changes. Core Scientific appointed Steve Smith to its board of directors. Smith will also serve on the Nominating and Corporate Governance Committee. He brings over 35 years of experience in the data center and technology sectors. At the company's 2026 Annual Meeting of Stockholders, five individuals were elected to the board to serve terms until the 2027 Annual Meeting. These developments highlight strategic adjustments in both operational capacity and corporate governance.